Rxivist logo

Author: Ofir Cohen

  • Most recently observed institution: Broad Institute of MIT and Harvard

Rankings

  • All-time downloads: 9,774 (rank: 7,487 out of 364,857)
  • Categories:
    • cancer biology: 3,479 (rank: 675 out of 24,717)
    • genomics: 6,295 (rank: 2,484 (tie) out of 39,301)

Downloads per author, site-wide

Preprints

A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors

genomics more details view paper
  • Downloaded 6,295 times
  • Download rankings, all-time:
    • Site-wide: 470 out of 84,802
    • In genomics: 102 out of 5,471
  • Year to date:
    • Site-wide: 252 out of 84,802
  • Since beginning of last month:
    • Site-wide: 650 out of 84,802

Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer

cancer biology more details view paper
  • Downloaded 1,317 times
  • Download rankings, all-time:
    • Site-wide: 6,859 out of 84,802
    • In cancer biology: 184 out of 2,968
  • Year to date:
    • Site-wide: 5,680 out of 84,802
  • Since beginning of last month:
    • Site-wide: 5,060 out of 84,802

Opposing immune and genetic forces shape oncogenic programs in synovial sarcoma

cancer biology more details view paper
  • Downloaded 1,003 times
  • Download rankings, all-time:
    • Site-wide: 10,749 out of 84,802
    • In cancer biology: 307 out of 2,968
  • Year to date:
    • Site-wide: 4,501 out of 84,802
  • Since beginning of last month:
    • Site-wide: 5,141 out of 84,802

The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer

cancer biology more details view paper
  • Downloaded 796 times
  • Download rankings, all-time:
    • Site-wide: 15,352 out of 84,802
    • In cancer biology: 441 out of 2,968
  • Year to date:
    • Site-wide: 3,230 out of 84,802
  • Since beginning of last month:
    • Site-wide: 3,322 out of 84,802

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

cancer biology more details view paper
  • Downloaded 363 times
  • Download rankings, all-time:
    • Site-wide: 42,194 out of 84,802
    • In cancer biology: 1,327 out of 2,968
  • Year to date:
    • Site-wide: 19,259 out of 84,802
  • Since beginning of last month:
    • Site-wide: 18,968 out of 84,802

PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News